Poggi A, Costa P, Morelli L, Cantoni C, Pella N, Spada F, Biassoni R, Nanni L, Revello V, Tomasello E, Mingari M C, Moretta A, Moretta L
Istituto Nazionale per la Ricerca sul Cancro e Centro Biotecnologie Avanzate, Genova, Italy.
Eur J Immunol. 1996 Jun;26(6):1266-72. doi: 10.1002/eji.1830260613.
In this study, we show that NKRP1A is expressed and functions on a subset of immature human thymocytes. We took advantage of the monoclonal antibody (mAb) 191B8 that was obtained by immunizing mice with cultured human thymocytes characterized by an immature surface phenotype [CD2- CD3- CD4- CD8- stem cell factor receptor (SCFR)+] and expressing cytoplasmic CD3 epsilon chain. The 191B8 antibody homogeneously reacted with the immunizing population but not with most unfractionated thymocytes. It stained a minor population of resting immature thymocytes co-expressing CD34, SCFR, or both. Following culture of the CD34+ or CD34- fractions of CD2- CD3- CD4- CD8- purified immature thymocytes with recombinant interleukin-2 (rIL-2), the 191B8-defined antigen was expressed on virtually all cells even when 191B8+ cells were removed from the starting population. On the other hand, no 191B8+ cells were detected in fresh or cultured thymocytes expressing a more mature phenotype. Biochemical analysis of 191B8 mAb-reactive molecules revealed, under non-reducing conditions, two bands displaying apparent molecular masses of 80 and 44 kDa and a single band of 44 kDa under reducing conditions. Digestion with proteases indicated that the 80-kDa form represented a homodimeric form of two 44-kDa molecules, while deglycosylation with N-glycanase suggested the existence of four N-glycosylation sites. Transfection of COS7 or NIH3T3 cells with hNKRP1A cDNA showed that the 191B8 mAb recognized NKRP1A as shown by both immunofluorescence analysis and immunoprecipitation experiments. Functional studies showed that the 191B8/NKRP1A molecule mediated strong inhibition of the cytolytic activity of cultured CD2- CD3- immature thymocytes against a panel of tumor target cells. More importantly, 191B8 mAb induced proliferation of CD2- CD3- fresh thymocytes which was not increased by rIL-2. Thus, we propose that NKRP1A molecules, which are expressed in highly immature thymocytes, may play a regulatory role in their growth and function.
在本研究中,我们发现NKRP1A在一部分未成熟的人类胸腺细胞中表达并发挥功能。我们利用了单克隆抗体(mAb)191B8,该抗体是通过用具有未成熟表面表型[CD2-CD3-CD4-CD8-干细胞因子受体(SCFR)+]并表达细胞质CD3ε链的培养人类胸腺细胞免疫小鼠而获得的。191B8抗体与免疫群体均匀反应,但不与大多数未分离的胸腺细胞反应。它对一小部分共表达CD34、SCFR或两者的静止未成熟胸腺细胞进行染色。在用重组白细胞介素-2(rIL-2)培养CD2-CD3-CD4-CD8-纯化未成熟胸腺细胞的CD34+或CD34-组分后,即使从起始群体中去除191B8+细胞,191B8定义的抗原也几乎在所有细胞上表达。另一方面,在表达更成熟表型的新鲜或培养胸腺细胞中未检测到191B8+细胞。对191B8 mAb反应性分子的生化分析显示,在非还原条件下,有两条带,表观分子量分别为80和44 kDa,在还原条件下有一条44 kDa的带。蛋白酶消化表明,80 kDa形式代表两个44 kDa分子的同二聚体形式,而用N-糖苷酶进行去糖基化表明存在四个N-糖基化位点。用hNKRP1A cDNA转染COS7或NIH3T3细胞表明,如免疫荧光分析和免疫沉淀实验所示,191B8 mAb识别NKRP1A。功能研究表明,191B8/NKRP1A分子强烈抑制培养的CD2-CD3-未成熟胸腺细胞对一组肿瘤靶细胞的细胞溶解活性。更重要的是,191B8 mAb诱导CD2-CD3-新鲜胸腺细胞增殖,而rIL-2并未增加这种增殖。因此,我们提出在高度未成熟胸腺细胞中表达的NKRP1A分子可能在其生长和功能中起调节作用。